Download Free Sample Report

AI Imaging and Diagnostics Software Market, Global Outlook and Forecast 2023-2029

AI Imaging and Diagnostics Software Market, Global Outlook and Forecast 2023-2029

  • Published on : 14 March 2023
  • Pages :64
  • Report Code:SMR-7602327

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

This report aims to provide a comprehensive presentation of the global market for AI Imaging and Diagnostics Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Imaging and Diagnostics Software. This report contains market size and forecasts of AI Imaging and Diagnostics Software in global, including the following market information:
  • Global AI Imaging and Diagnostics Software Market Revenue, 2018-2023, 2024-2029, ($ millions)
  • Global top five companies in 2022 (%)
The global AI Imaging and Diagnostics Software market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
On-premise Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of AI Imaging and Diagnostics Software include Siemens Healthineers AG, GE Healthcare, IBM Watson Health, Philips Healthcare, AliveCor Inc., Zebra Medical Vision, Inc., Riverain Technologies, Vuno, Inc. and Aidoc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the AI Imaging and Diagnostics Software companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global AI Imaging and Diagnostics Software Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global AI Imaging and Diagnostics Software Market Segment Percentages, by Type, 2022 (%)
  • On-premise
  • Cloud Based
Global AI Imaging and Diagnostics Software Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global AI Imaging and Diagnostics Software Market Segment Percentages, by Application, 2022 (%)
  • Hospitals
  • Diagnostic Centers
  • Others
Global AI Imaging and Diagnostics Software Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global AI Imaging and Diagnostics Software Market Segment Percentages, By Region and Country, 2022 (%)
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
  • Key companies AI Imaging and Diagnostics Software revenues in global market, 2018-2023 (estimated), ($ millions)
  • Key companies AI Imaging and Diagnostics Software revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
  • Siemens Healthineers AG
  • GE Healthcare
  • IBM Watson Health
  • Philips Healthcare
  • AliveCor Inc.
  • Zebra Medical Vision, Inc.
  • Riverain Technologies
  • Vuno, Inc.
  • Aidoc
  • Neural Analytics
  • Imagen Technologies
  • Digital Diagnostics, Inc.
  • Google (Subsidiary of Alphabet, Inc.)
  • Heartflow
Outline of Major Chapters:
  • Chapter 1: Introduces the definition of AI Imaging and Diagnostics Software, market overview.
  • Chapter 2: Global AI Imaging and Diagnostics Software market size in revenue.
  • Chapter 3: Detailed analysis of AI Imaging and Diagnostics Software company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Sales of AI Imaging and Diagnostics Software in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: The main points and conclusions of the report.